Stephen Kraus - 12 May 2024 Form 4 Insider Report for NeueHealth, Inc. (NEUE)

Role
Director
Signature
/s/ Eric Halverson for Stephen Kraus, Attorney-in-Fact
Issuer symbol
NEUE
Transactions as of
12 May 2024
Net transactions value
$0
Form type
4
Filing time
14 May 2024, 21:27:55 UTC
Previous filing
16 May 2023
Next filing
15 May 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NEUE Common Stock Options Exercise $0 +4,755 +400% $0.000000 5,944 12 May 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NEUE Restricted Stock Units Options Exercise $0 -4,755 -100% $0.000000* 0 12 May 2024 Common Stock 4,755 Direct F1, F2
transaction NEUE Restricted Stock Units Award $0 +10,500 $0.000000 10,500 13 May 2024 Common Stock 10,500 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F2 All of these restricted stock units vested on May 12, 2024, one year from the grant date.
F3 All of these restricted stock units vest on May 13, 2025, one year from the grant date.